NO964032D0 - Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand - Google Patents

Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Info

Publication number
NO964032D0
NO964032D0 NO964032A NO964032A NO964032D0 NO 964032 D0 NO964032 D0 NO 964032D0 NO 964032 A NO964032 A NO 964032A NO 964032 A NO964032 A NO 964032A NO 964032 D0 NO964032 D0 NO 964032D0
Authority
NO
Norway
Prior art keywords
ligand
flk
flt
covalent dimers
kit
Prior art date
Application number
NO964032A
Other languages
English (en)
Other versions
NO964032L (no
Inventor
Karl H Nocka
Robert B Lobell
Original Assignee
Cytomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomed Inc filed Critical Cytomed Inc
Publication of NO964032D0 publication Critical patent/NO964032D0/no
Publication of NO964032L publication Critical patent/NO964032L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO964032A 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand NO964032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/220,379 US5525708A (en) 1994-03-28 1994-03-28 Covalent dimer of kit ligand
PCT/US1995/003866 WO1995026199A1 (en) 1994-03-28 1995-03-28 Covalent dimers of kit ligand and flt-3/flk-2 ligand

Publications (2)

Publication Number Publication Date
NO964032D0 true NO964032D0 (no) 1996-09-25
NO964032L NO964032L (no) 1996-11-28

Family

ID=22823324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964032A NO964032L (no) 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Country Status (10)

Country Link
US (1) US5525708A (no)
EP (1) EP0759767A1 (no)
JP (1) JPH09512706A (no)
AU (1) AU2199895A (no)
CA (1) CA2186496A1 (no)
FI (1) FI963900A (no)
HU (1) HU9602682D0 (no)
MX (1) MX9604394A (no)
NO (1) NO964032L (no)
WO (1) WO1995026199A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
NZ314644A (en) 1993-05-24 2000-11-24 Immunex Corp Use of flt3-ligands as a growth stimulator of stem cells in the transplantation of tissue
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
US7294331B2 (en) * 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
US20020034517A1 (en) * 1995-10-04 2002-03-21 Kenneth Brasel Dendritic cell stimulatory factor
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US7361330B2 (en) * 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma
US5885962A (en) * 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method
AU705647B2 (en) * 1996-07-10 1999-05-27 Immunex Corporation Method of activating dendritic cells
US6017527A (en) * 1996-07-10 2000-01-25 Immunex Corporation Activated dendritic cells and methods for their activation
BR9808514A (pt) * 1997-04-11 2000-05-23 Searle & Co Proteìnas quiméricas do ligante flt3
US20030022233A1 (en) 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
US20030077263A1 (en) * 1999-10-29 2003-04-24 Immunex Corporation Method of activating dendritic cells
WO2006055260A2 (en) 2004-11-05 2006-05-26 Northwestern University Use of scf and g-csf in the treatment of cerebral ischemia and neurological disorders
US8093046B2 (en) * 2006-05-31 2012-01-10 Philadelphia Health and Education Corporation d/b/c Drexel University College of Medicine CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions
AR077764A1 (es) * 2009-07-20 2011-09-21 Univ Nat Cheng Kung Polipeptidos selectivos para integrina alfavbeta 3 conjugados a una variante de seroalbumina humana (hsa) y usos farmaceuticos de los mismos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
EP1241258A3 (en) * 1989-10-16 2003-12-10 Amgen Inc. Stem cell factor
JP2657113B2 (ja) * 1989-10-16 1997-09-24 アムジエン・インコーポレーテツド 幹細胞因子
AU8196891A (en) * 1990-06-25 1992-01-23 Immunex Corporation Mast cell growth factor
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
WO1993005795A1 (en) * 1991-09-13 1993-04-01 Boron Biologicals, Inc. Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
ATE206309T1 (de) * 1992-04-23 2001-10-15 Sloan Kettering Inst Cancer Ligand für den c-kit-rezepten und verfahren zu seiner nutzung
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors

Also Published As

Publication number Publication date
WO1995026199A1 (en) 1995-10-05
MX9604394A (es) 1997-07-31
CA2186496A1 (en) 1995-10-05
AU2199895A (en) 1995-10-17
EP0759767A1 (en) 1997-03-05
FI963900A (fi) 1996-11-27
HU9602682D0 (en) 1996-11-28
US5525708A (en) 1996-06-11
NO964032L (no) 1996-11-28
FI963900A0 (fi) 1996-09-27
JPH09512706A (ja) 1997-12-22

Similar Documents

Publication Publication Date Title
NO964032D0 (no) Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand
DE69624356D1 (de) Drehregner und standfuss
BR1100574A (pt) Ligantes macrocìclicos e complexos
DE68926530D1 (de) Tragbarer Rechner und zugehöriges Verfahren
NO963814D0 (no) Inhibitor av det 265 proteolytiske kompleks og 205 proteasomet inneholdt deri
NO172904C (no) Legeringer og anvendelse av disse
NO914365D0 (no) Framgangsmaate for sementering av broennhull ved bruk av vaesketapshindrende additiver og dispergeringsmidler
NO975759D0 (no) Inokuleringsmiddel og fremgangsmåte for fremstilling av inokuleringsmiddel
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
NO971015L (no) Forbindelser og metoder for behandling av cancer
NO971900D0 (no) Blandinger og behandling av multippel sklerose
KR910700046A (ko) 포르피린의 생산 및 용도
NO961790L (no) Kombinasjon av apparatsokkel og innsatsdel
EP0786001A4 (en) CHEMOKIN-LIKE PROTEINS AND THEIR USE
NO991465D0 (no) FremgangsmÕter og preparater for lipidisering av hydrofile molekyler
LV10738A (lv) Homogenais enzimu imunopetisanas panemiens un komplekts ta realizesanai
DE59501490D1 (de) Kalibrierung von Asselwalzen
DE69128736T2 (de) Interferenzschicht und Lampe
DE69032651D1 (de) Ausbildungsverfahren und gegenstände dafür
FI972055A0 (fi) Syljen analysointimenetelmä
ATE204273T1 (de) 5ht1dalpha und 5ht2a ligande
DE68928830T2 (de) Volumenhologramm und Verfahren zur Herstellung desselben
DE69719885T2 (de) Spielbauelement und Spielbausatz
DE69324588T2 (de) Fluorierungsreagenz und fluorierungsverfahren
DK417589A (da) Fremgangsmaade og kredsloeb til faseforskydning